The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Social responsibility is an emerging area of importance for all health care supply chain professionals to understand and participate in. This webinar…
On-Demand Educational Webinars
In order to compare baseline costs to savings and determine areas of compliance risk, supply chain professionals need to work closely with their…
Podcasts
A value analysis process to verify the achievement of the outcomes desired will result in making decisions based on the data, celebrating achieveme
On-Demand Educational Webinars
The Intermountain Healthcare Supply Chain Organization has embarked on strategy to drive costs out of the healthcare supply chain. As a part of that…
Webcast
Supply chain is in the unique position, working with so many different disciplines within the hospital, that it is natural that they initiate conve
On-Demand Educational Webinars
This webinar provides an overview of the reasons for drug shortages, recent advocacy efforts to ameliorate the situation, and action steps…